Clinical Trials
2 trialsNCT06909474 2025-04-03
Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT04014374 2024-07-24
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
Kyowa Kirin Co., Ltd.
Recruiting